Triptorelin and cetrorelix induce immune responses and affect uterine development and expressions of genes and proteins of ESR1, LHR, and FSHR of mice

References

• Haviv F, Bush EN, Knittle J, Greer J. LHRH antagonists. Pharm Biotechnol 1998;11:131–149.
   PubMedGoogle Scholar
• Bartolome JA, Sozzi A, McHale J, et al. Resynchronisation of ovulation and timed insemination in lactating dairy cows, II assigning protocols according to stages of the estrous cycle, or presence of ovarian cysts or anestrus. Theriogenology 2005;63:1628–1642.
   PubMed Web of Science ®Google Scholar
• Sullivan SK, Hoare SR, Fleck BA, et al. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: implications for structure-activity relationships and insurmountable antagonism. Biochem Pharmacol 2006;72:838–849.
   PubMed Web of Science ®Google Scholar
• Danforth DR, Arbogasta LK, Friedman CI. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril 2005;83:1333–1338.
   PubMed Web of Science ®Google Scholar
• Yaqin M, Ping P, Ran Z, et al. Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist. Reprod Sci 2010;17:68–77.
   PubMed Web of Science ®Google Scholar
• Schneider F, Tomek W, Grundker C. Gonadotropin-releasing hormone (GnRH) and its natural analogues: a review. Theriogenology 2006;66:691–709.
   PubMed Web of Science ®Google Scholar
• Li X, Kang X, Deng Q, et al. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study. Reprod Biol Endocrinol 2013;11:1–8.
   PubMed Web of Science ®Google Scholar
• Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874–885.
   PubMed Web of Science ®Google Scholar
• Coccia ME, Comparetto C, Bracco GL, Scarselli G. GnRH antagonists. Eur J Obstet Gynecol Reprod Biol 2004;115:S44–S56.
   PubMed Web of Science ®Google Scholar
• Huriye A, Parlakgumus EB, Kilicdag FA, et al. GNRH agonists and antagonists in rescue for cyclophosphamideinduced ovarian damage: friend or foe? Arch Gynecol Obstet 2015;291:1403–1410.
   PubMed Web of Science ®Google Scholar
• Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat 2009;117:561–567.
   PubMed Web of Science ®Google Scholar
• Lemos CN, Reis FM, Pena GN, et al. Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide. Reprod Biol Endocrinol 2010;8:51.
   PubMed Web of Science ®Google Scholar
• Jiang C, Zheng R, Zhang Y. Study on mini-dose depot gonadotropin-releasing hormone agonist for short protocol. Chinese J Fam Plan 2010;7:423–426.
   Google Scholar
• Sun P, Yu X, Yang Y, et al. Efficacy analysis on different dose of GnRHa treating adenomyosis complicated with sterility. Mod Diagn Treat 2007;18:25–26.
   Google Scholar
• Felberbaum RE, Germer U, Ludwig M, et al. Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist cetrorelix. Hum Reprod 1998;13:1660–1668.
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Heitbrink MA, Hompes PG, et al. Quantitative MRI of uterine leiomyomas during Triptorelin treatment: reproducibility of volume assessment and predictability of treatment response. Magn Reson Imaging 1996;14:127–135.
   Web of Science ®Google Scholar
• Peng P, Yang DZ, Zheng CY, et al. Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats. Chinese J Obstet Gynecol 2007;42:546–550.
   Google Scholar
• Soltysik K, Czekaj P, Suszka-Switek A, et al. Changes in the subcellular and tissue location of estrogen and progesterone receptors in rat uterus after long-term treatment with analogs of gonadoliberin. Ginekol Pol 2014;85:254–263.
   PubMed Web of Science ®Google Scholar
• Wei S, Ouyang X, Ayimuguli, et al. GnRHa active immunity regulates expression of LHR protein and development of uteri in ewes. J Appl Anim Res 2013;41:375–381.
   Web of Science ®Google Scholar
• Hosseini MA, Aleyasin A, Saeedi H, Mahdavi A. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients. J Obstet Gynaecol Res 2010;36:605–610.
   PubMed Web of Science ®Google Scholar
• Kerimoglu OS. Low dose GnRH antagonist does not help prevent a premature LH surge. Fertil Week 2014;28:10–11.
   Google Scholar
• Bertschinger HT, Jago I, Nothing JO. Repeated use of the GnRH analogue deslorelin to down-regulate reproduction in male cheetahs (Acinonyx jubatus). Theriogenology 2006;66:1762–1768.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tian Y, Zhao X, et al. Immunization of dogs with recombinant GnRH-1 suppresses the development of reproductive function. Theriogenology 2015;83:314–319.
   PubMed Web of Science ®Google Scholar
• Levy JK, Friary JA, Miller LA, et al. Long-term fertility control in female cats with GonaCon™, a GnRH immunocontraceptive. Theriogenology 2011;76:1517–1525.
   PubMed Web of Science ®Google Scholar
• Massei G, Cowan DP, Coats J, et al. Long-term effects of immunocontraception on wild boar fertility, physiology and behaviour. Wildlife Res 2012;39:378–385.
   Google Scholar
• Crawford JL, Heath DA, Haydon LJ, et al. Gene expression and secretion of LH and FSH in relation to gene expression of GnRH receptors in the brushtail possum (Trichosurus vulpecula) demonstrates highly conserved mechanisms. Reproduction 2009;137:129–140.
   PubMed Web of Science ®Google Scholar
• Anjum S, Krishna A, Sridaran R, Tsutsui K. Localization of gonadotropin-releasing hormone (GnRH), gonadotropin-inhibitory hormone (GnIH), kisspeptin andGnRH receptor and their possible roles in testicular activities from birth to senescence in mice. J Exp Zool A Ecol Genet Physiol 2012;317:630–644.
   PubMed Web of Science ®Google Scholar
• Gong Z, Wei S, Wei M. GnRH-A enhanses LH and FSH secretion, ovarian development in female rabbits. Basic Clin Med 2011;31:13–18.
   Google Scholar
• Wei S, Gong Z, Wei M. GnRH-A immunization and the changes of reproductive hormone concentration in female rabbits. Acta Lab Anim Sci Sinica 2010;18:247–250.
   Google Scholar
• Wei S, Zhang J. Preparation of GnRH-A antigen and researches on efficacies of active immunization castration with different dosage. J Northwest Univ National 2008;19:49–52.
   Google Scholar
• Wei S, Gong Z, Ma W, Wei M. Effects of GnRH agonist on reproductive functions of female rabbits. Anim Sci Papers Rep 2012;30:73–86.
   Web of Science ®Google Scholar
• Seitz S, Buchholz S, Schally AV, et al. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125. BMC Cancer 2014;14:847.
   PubMed Web of Science ®Google Scholar
• Leung PC, Cheng CK, Zhu XM. Multi-factorial role of GnRH-I and GnRH-II in the human ovary. Mol Cell Endocrinol 2003;202:145–153.
   PubMed Web of Science ®Google Scholar
• Horvath JE, Bajo AM, Schally AV, et al. Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats. Proc Natl Acad Sci USA 2002;99:15048–15053.
   PubMed Web of Science ®Google Scholar
• Jasonni VM, Danna R, Mancuso A, et al. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy. Acta Obstet Gynecol Scand 2001;80:956–958.
   PubMed Web of Science ®Google Scholar
• Shunichiro T, Kentaro T, Izumi I, et al. MRI evaluation of the uterine structure after myomectomy. Gynecol Obstet Invest 2006;61:106–110.
   PubMed Web of Science ®Google Scholar
• Friedman AJ, Hoffman DI, Comite F. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Obstet Gynecol 1991;77:720–725.
   PubMed Web of Science ®Google Scholar
• Suszka-Świtek A, Czekaj P, Pająk J, et al. Morphological and enzymatic changes caused by a long-term treatment of female rats with a low dose of gonadoliberin agonist and antagonist. Med Sci Monit 2012;18:BR315–BR330.
   PubMed Web of Science ®Google Scholar
• Magdolna K, Andrew VS. Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist Cetrorelix and LHRH agonist Triptorelin on the gene expression of pituitary LHRH receptors in rats. Proc Natl Acad Sci USA 2001;98:12197–12202.
   PubMed Web of Science ®Google Scholar
• Schirman-Hildesheim TD, Bar T, Ben AN. Differential gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acid expression patterns in different tissues of the female rat across the estrous cycle. Endocrinology 2005;146:3401–3408.
   PubMed Web of Science ®Google Scholar